Substance / Medication

Magnesium phosphate

Overview

Active Ingredient
magnesium phosphate
RxNorm CUI
29164

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effect of cold-setting calcium- and magnesium phosphate matrices on protein expression in osteoblastic cells.
Ewald Andrea, Helmschrott Kerstin, Knebl Georg et al. · J Biomed Mater Res B Appl Biomater · 2011
PMID: 21210513Observational
Is combined calcium/magnesium phosphate binder really noninferior to sevelamer hydrochloride?
Spasovski Goce, Vanholder Raymond · Nephrol Dial Transplant · 2011
PMID: 21339309Observational
Formation of insoluble magnesium phosphates during growth of the archaea Halorubrum distributum and Halobacterium salinarium and the bacterium Brevibacterium antiquum.
Smirnov Aleksey, Suzina Natalia, Chudinova Natalia et al. · FEMS Microbiol Ecol · 2005
PMID: 16329899Observational
Stabilization and solidification of metal-laden wastes by compaction and magnesium phosphate-based binder.
Rao A J, Pagilla K R, Wagh A S · J Air Waste Manag Assoc · 2000
PMID: 11055158Observational
Magnesium phosphate minerals and cements as bone substitute materials.
Kaiser Friederike, Schröter Lena, Ignatius Anita et al. · Acta Biomater · 2026
PMID: 41520695Review
Multifaceted role of Mg in mitigating cold stress during digestate treatment via anammox-induced magnesium phosphate mineralization.
Li Jiayi, Zhang Yu, Chen Yongxing et al. · Bioresour Technol · 2026
PMID: 41421676Other
Injectable composite gels containing magnesium phosphate for bone regeneration: Analysis of hydration and in vivo study.
Mabrouk Mostafa, Aboelnasr Mohamed A, Shiomoto Shohei et al. · Biomater Adv · 2026
PMID: 41237505Preclinical
Biodegradable and osteoconductive sodium alginate-gelatin/amorphous magnesium phosphate 3D-printed scaffolds for craniofacial bone regeneration.
de Souza Joyce R, Mendes Soares Igor P, Anselmi Caroline et al. · J Mech Behav Biomed Mater · 2026
PMID: 41317696Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Magnesium phosphate (substance)
SNOMED CT
31731008
UMLS CUI
C0065527
RxNorm CUI
29164

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.